Comparison 23. Oral propranolol + topical timolol maleate versus oral propranolol.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Adverse events in general | 1 | 26 | Risk Ratio (M‐H, Random, 95% CI) | 0.33 [0.04, 2.80] |
2 Other measures of resolution: colour fading/visual analogue scale score | 1 | 31 | Mean Difference (IV, Random, 95% CI) | 1.18 [0.09, 2.27] |
3 Other measures of resolution: size reduction/visual analogue scale score | 1 | 31 | Mean Difference (IV, Random, 95% CI) | 0.41 [‐0.84, 1.66] |
4 Other measures of resolution: size reduction > 50% | 1 | 26 | Risk Ratio (M‐H, Random, 95% CI) | 1.22 [0.79, 1.88] |